POLYMED.NS Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 13:00):

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I...

Stats
Объем за сегодня	52 364.00
Средний объем	78 714.00
Рыночная капитализация	157.01B
EPS	INR0 ( 2024-02-02 )
Дата следующего отчета о доходах	( INR0 ) 2024-05-17
Last Dividend	INR3.00 ( 2023-09-21 )
Next Dividend	INR0 ( N/A )
P/E	63.09
ATR14	INR2.36 (0.14%)

Объем Корреляция

Длинно: -0.43 (neutral)

Кратко: -0.94 (very strong negative)

Signal:(48.036) Neutral

Poly Medicure Limited Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Poly Medicure Limited Корреляция - Валюта/Сырье

0.65
( moderate )

0.34
( neutral )

0.47
( neutral )

0.48
( neutral )

-0.14
( neutral )

-0.08
( neutral )

Poly Medicure Limited Финансовые показатели

Annual	2022
Выручка:	INR11.15B
Валовая прибыль:	INR7.09B (63.61 %)
EPS:	INR18.69

FY	2022
Выручка:	INR11.15B
Валовая прибыль:	INR7.09B (63.61 %)
EPS:	INR18.69

FY	2022
Выручка:	INR9.17B
Валовая прибыль:	INR4.84B (52.75 %)
EPS:	INR15.28

FY	2021
Выручка:	INR7.75B
Валовая прибыль:	INR4.39B (56.59 %)
EPS:	INR15.25

Financial Reports:

No articles found.

Poly Medicure Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR2.50 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Poly Medicure Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.15 - low (37.80%) | Divividend Growth Potential Score: 5.12 - Stable (2.45%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.375	2012-09-13
Last Dividend	INR3.00	2023-09-21
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	15	--
Total Paid Out	INR20.13	--
Avg. Dividend % Per Year	0.27%	--
Score	2.15	--
Div. Sustainability Score	4.15
Div.Growth Potential Score	5.12
Div. Directional Score	4.63	--

Next Divdend (Est)
(2024-12-18)

INR3.29 Estimate 3.28 %

Dividend Stability

0.26 Very Poor

Dividend Score

2.15

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.00	0.80%
2019	INR2.00	0.90%
2020	INR2.00	0.92%
2021	INR2.50	0.49%
2022	INR2.50	0.26%
2023	INR3.00	0.33%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUMICHEM.NS	Dividend Junior	2023-07-20	Annually	5	0.17%
NATCOPHARM.NS	Dividend Junior	2023-08-22	Semi-Annually	29	0.68%
HITECHCORP.NS	Dividend Junior	2023-06-30	Annually	17	0.30%
CANBK.NS	Dividend Junior	2023-06-14	Sporadic	22	1.58%
RICOAUTO.NS	Dividend Junior	2023-09-22	Annually	22	0.54%
L&TFH.NS	Dividend Junior	2023-07-21	Annually	12	0.77%
FOCUS.NS	Dividend Junior	2023-08-18	Sporadic	6	1.23%
APCOTEXIND.NS	Dividend Junior	2023-06-12	Annually	22	0.99%
TATAPOWER.NS	Dividend Junior	2023-06-07	Annually	29	0.85%
NRBBEARING.NS	Dividend Junior	2023-09-22	Annually	23	1.22%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.191	1.500	6.19	9.28	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.193	1.500	8.97	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	30.75	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	10.15	2.00	6.62	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.15	2.00	4.93	9.85	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.650	1.000	2.50	2.50	[0.2 - 0.8]
operatingProfitMarginTTM	0.248	1.000	7.04	7.04	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.15

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	64.91	1.000	3.54	0	[1 - 100]
returnOnEquityTTM	0.193	2.50	9.34	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.15	2.00	6.62	9.85	[0 - 30]
dividendYielPercentageTTM	0.178	1.500	5.54	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.15	2.00	6.62	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	329.93	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0746	1.000	-0.634	0	[0.1 - 0.5]
Total Score				5.12

Poly Medicure Limited

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.